Future Virology

Mechanisms of Chikungunya virus disease informed by Ross River virus research
pp. 509-511(3)
Authors: Srivastava, Umang; Nelson, Michelle; Su, Yung-Chang; Mahalingam, Suresh

Bulletin Board
pp. 513-515(3)

Telbivudine for the treatment of hepatitis B disease
pp. 517-527(11)
Authors: Tsunoda, Shirley M; Hassanein, Tarek

Antiviral drug development: progress and pitfalls
pp. 529-532(4)
Authors: Coutsinos, Dimitrios; Sloan, Richard; Wainberg, Mark A

Revised model for early memory T-cell protection against respiratory virus challenge
pp. 533-536(4)
Authors: Tripp, Ralph A; Tompkins, S Mark

Function is the key: impact of interferon on HCV-specific CD8⁺ T cells during acute HCV infection
pp. 537-542(6)
Authors: Bengsch, Bertram; Thimme, Robert

Enveloped viral fusion: insights into the fusion of hepatitis B viruses
pp. 543-552(10)
Authors: Chojnacki, Jakub; Grgacic, Elizabeth VL

Therapeutically targeting RNA viruses via lethal mutagenesis
pp. 553-566(14)
Authors: Graci, Jason D; Cameron, Craig E

Human herpesvirus-6 infections and infection-preventative measures in transplant recipients
pp. 567-578(12)
Authors: Ogata, Masao; Kadota, Jun-ichi

Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection
pp. 579-593(15)
Author: Tsunoda, Ikuo

Therapeutic and prophylactic drugs to treat orthopoxvirus infections
pp. 595-612(18)
Authors: Parker, Scott; Handley, Lauren; Buller, R Mark

Acknowledgements
pp. 618-618(1)

Corrigendum
pp. 619-619(1)